We will explore the new and updated guidelines for reporting COVID-19 and vaping-related disorders, new guidance for reporting of long anti-diabetic injectables for Type 2 Diabetes Mellitus as well as guideline revisions.
Login
Accessing this course requires a login. Please enter your credentials below!
